|
1
|
Pui CH, Gajjar AJ, Kane JR, Qaddoumi IA
and Pappo AS: Challenging issues in pediatric oncology. Nat Rev
Clin Oncol. 8:540–549. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Inaba T, Roberts WM, Shapiro LH, Jolly KW,
Raimondi SC, Smith SD and Look AT: Fusion of the leucine zipper
gene HLF to the E2A gene in human acute B-lineage leukemia.
Science. 257:531–534. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hunger SP, Ohyashiki K, Toyama K and
Cleary ML: Hlf, a novel hepatic bZIP protein, shows altered
DNA-binding properties following fusion to E2A in t(17;19) acute
lymphoblastic leukemia. Genes Dev. 6:1608–1620. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Raimondi SC, Privitera E, Williams DL,
Look AT, Behm F, Rivera GK, Crist WM and Pui CH: New recurring
chromosomal translocations in childhood acute lymphoblastic
leukemia. Blood. 77:2016–2022. 1991.PubMed/NCBI
|
|
5
|
Inukai T, Hirose K, Inaba T, Kurosawa H,
Hama A, Inada H, Chin M, Nagatoshi Y, Ohtsuka Y, Oda M, et al:
Hypercalcemia in childhood acute lymphoblastic leukemia: Frequent
implication of parathyroid hormone-related peptide and E2A-HLF from
translocation 17;19. Leukemia. 21:288–296. 2007. View Article : Google Scholar
|
|
6
|
Greenbaum S and Zhuang Y: Identification
of E2A target genes in B lymphocyte development by using a gene
tagging-based chromatin immunoprecipitation system. Proc Natl Acad
Sci USA. 99:15030–15035. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Massari ME and Murre C: Helix-loop-helix
proteins: Regulators of transcription in eucaryotic organisms. Mol
Cell Biol. 20:429–440. 2000. View Article : Google Scholar
|
|
8
|
Quong MW, Romanow WJ and Murre C: E
protein function in lymphocyte development. Annu Rev Immunol.
20:301–322. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hunger SP, Li S, Fall MZ, Naumovski L and
Cleary ML: The proto-oncogene HLF and the related basic leucine
zipper protein TEF display highly similar DNA-binding and
transcriptional regulatory properties. Blood. 87:4607–4617.
1996.PubMed/NCBI
|
|
10
|
Hunger SP, Brown R and Cleary ML:
DNA-binding and transcriptional regulatory properties of hepatic
leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia
chimera E2A-HLF. Mol Cell Biol. 14:5986–5996. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fischer U, Forster M, Rinaldi A, Risch T,
Sungalee S, Warnatz HJ, Bornhauser B, Gombert M, Kratsch C, Stütz
AM, et al: Genomics and drug profiling of fatal TCF3-HLF-positive
acute lymphoblastic leukemia identifies recurrent mutation patterns
and therapeutic options. Nat Genet. 47:1020–1029. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoshihara T, Inaba T, Shapiro LH, Kato JY
and Look AT: E2A-HLF-mediated cell transformation requires both the
trans-activation domains of E2A and the leucine zipper dimerization
domain of HLF. Mol Cell Biol. 15:3247–3255. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Inaba T, Inukai T, Yoshihara T, Seyschab
H, Ashmun RA, Canman CE, Laken SJ, Kastan MB and Look AT: Reversal
of apoptosis by the leukaemia-associated E2A-HLF chimaeric
transcription factor. Nature. 382:541–544. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Duque-Afonso J, Smith KS and Cleary ML:
Conditional expression of E2A-HLF induces B-cell precursor death
and myeloproliferative-like disease in knock-in mice. PLoS One.
10:e01432162015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Honda H, Inaba T, Suzuki T, Oda H, Ebihara
Y, Tsuiji K, Nakahata T, Ishikawa T, Yazaki Y and Hirai H:
Expression of E2A-HLF chimeric protein induced T-cell apoptosis,
B-cell maturation arrest, and development of acute lymphoblastic
leukemia. Blood. 93:2780–2790. 1999.PubMed/NCBI
|
|
16
|
Smith KS, Rhee JW, Naumovski L and Cleary
ML: Disrupted differentiation and oncogenic transformation of
lymphoid progenitors in E2A-HLF transgenic mice. Mol Cell Biol.
19:4443–4451. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hirose K, Inukai T, Kikuchi J, Furukawa Y,
Ikawa T, Kawamoto H, Oram SH, Göttgens B, Kiyokawa N, Miyagawa Y,
et al: Aberrant induction of LMO2 by the E2A-HLF chimeric
transcription factor and its implication in leukemogenesis of
B-precursor ALL with t(17;19). Blood. 116:962–970. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Boer J, Yeung J, Ellu J, Ramanujachar
R, Bornhauser B, Solarska O, Hubank M, Williams O and Brady HJ: The
E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to
immortalize hematopoietic progenitors. Leukemia. 25:321–330. 2011.
View Article : Google Scholar
|
|
19
|
Inukai T, Inoue A, Kurosawa H, Goi K,
Shinjyo T, Ozawa K, Mao M, Inaba T and Look AT: SLUG, a
ces-1-related zinc finger transcription factor gene with
antiapoptotic activity, is a downstream target of the E2A-HLF
oncoprotein. Mol Cell. 4:343–352. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yeung J, O'Sullivan E, Hubank M and Brady
HJ: E4BP4 expression is regulated by the t(17;19)-associated
oncoprotein E2A-HLF in pro-B cells. Br J Haematol. 125:560–567.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dang J, Inukai T, Kurosawa H, Goi K, Inaba
T, Lenny NT, Downing JR, Stifani S and Look AT: The E2A-HLF
oncoprotein activates Groucho-related genes and suppresses Runx1.
Mol Cell Biol. 21:5935–5945. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kurosawa H, Goi K, Inukai T, Inaba T,
Chang KS, Shinjyo T, Rakestraw KM, Naeve CW and Look AT: Two
candidate downstream target genes for E2A-HLF. Blood. 93:321–332.
1999.
|
|
23
|
Yamasaki N, Miyazaki K, Nagamachi A,
Koller R, Oda H, Miyazaki M, Sasaki T, Honda ZI, Wolff L, Inaba T,
et al: Identification of Zfp521/ZNF521 as a cooperative gene for
E2A-HLF to develop acute B-lineage leukemia. Oncogene.
29:1963–1975. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Okuya M, Kurosawa H, Kikuchi J, Furukawa
Y, Matsui H, Aki D, Matsunaga T, Inukai T, Goto H, Altura RA, et
al: Up-regulation of survivin by the E2A-HLF chimera is
indispensable for the survival of t(17;19)-positive leukemia cells.
J Biol Chem. 285:1850–1860. 2010. View Article : Google Scholar :
|
|
25
|
Zhang X, Inukai T, Hirose K, Akahane K,
Kuroda I, Honna-Oshiro H, Kagami K, Goi K, Nakamura K, Kobayashi M,
et al: Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute
lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating
the expression of death receptors. Leukemia. 26:2483–2493. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bonini NM, Leiserson WM and Benzer S: The
eyes absent gene: Genetic control of cell survival and
differentiation in the developing Drosophila eye. Cell. 72:379–395.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bonini NM, Leiserson WM and Benzer S:
Multiple roles of the eyes absent gene in Drosophila. Dev Biol.
196:42–57. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tadjuidje E and Hegde RS: The Eyes Absent
proteins in development and disease. Cell Mol Life Sci.
70:1897–1913. 2013. View Article : Google Scholar :
|
|
29
|
Zimmerman JE, Bui QT, Steingrímsson E,
Nagle DL, Fu W, Genin A, Spinner NB, Copeland NG, Jenkins NA, Bucan
M, et al: Cloning and characterization of two vertebrate homologs
of the Drosophila eyes absent gene. Genome Res. 7:128–141. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang L, Yang N, Huang J, Buckanovich RJ,
Liang S, Barchetti A, Vezzani C, O'Brien-Jenkins A, Wang J, Ward
MR, et al: Transcriptional coactivator Drosophila eyes absent
homologue 2 is up-regulated in epithelial ovarian cancer and
promotes tumor growth. Cancer Res. 65:925–932. 2005.PubMed/NCBI
|
|
31
|
Farabaugh SM, Micalizzi DS, Jedlicka P,
Zhao R and Ford HL: Eya2 is required to mediate the pro-metastatic
functions of Six1 via the induction of TGF-β signaling,
epithelial-mesenchymal transition, and cancer stem cell properties.
Oncogene. 31:552–562. 2012. View Article : Google Scholar
|
|
32
|
Wen Z, Liang C, Pan Q and Wang Y: Eya2
overexpression promotes the invasion of human astrocytoma through
the regulation of ERK/MMP9 signaling. Int J Mol Med. 40:1315–1322.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vincent A, Hong SM, Hu C, Omura N, Young
A, Kim H, Yu J, Knight S, Ayars M, Griffith M, et al: Epigenetic
silencing of EYA2 in pancreatic adenocarcinomas promotes tumor
growth. Oncotarget. 5:2575–2587. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Forsberg EC, Prohaska SS, Katzman S,
Heffner GC, Stuart JM and Weissman IL: Differential expression of
novel potential regulators in hematopoietic stem cells. PLoS Genet.
1:e282005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ono R, Masuya M, Ishii S, Katayama N and
Nosaka T: Eya2, a Target Activated by Plzf, Is Critical for
PLZF-RARA-Induced Leukemogenesis. Mol Cell Biol. 37:e00585–e16.
2017. View Article : Google Scholar :
|
|
36
|
Ono R, Masuya M, Nakajima H, Enomoto Y,
Miyata E, Nakamura A, Ishii S, Suzuki K, Shibata-Minoshima F,
Katayama N, et al: Plzf drives MLL-fusion-mediated leuke-mogenesis
specifically in long-term hematopoietic stem cells. Blood.
122:1271–1283. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kitamura T, Koshino Y, Shibata F, Oki T,
Nakajima H, Nosaka T and Kumagai H: Retrovirus-mediated gene
transfer and expression cloning: Powerful tools in functional
genomics. Exp Hematol. 31:1007–1014. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hunger SP, Galili N, Carroll AJ, Crist WM,
Link MP and Cleary ML: The t(1;19)(q23;p13) results in consistent
fusion of E2A and PBX1 coding sequences in acute lymphoblastic
leukemias. Blood. 77:687–693. 1991.PubMed/NCBI
|
|
39
|
LeBrun DP: E2A basic helix-loop-helix
transcription factors in human leukemia. Front Biosci. 8:s206–s222.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Inukai T, Inaba T, Ikushima S and Look AT:
The AD1 and AD2 transactivation domains of E2A are essential for
the antiapoptotic activity of the chimeric oncoprotein E2A-HLF. Mol
Cell Biol. 18:6035–6043. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Morita S, Kojima T and Kitamura T: Plat-E:
An efficient and stable system for transient packaging of
retroviruses. Gene Ther. 7:1063–1066. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ono R, Nakajima H, Ozaki K, Kumagai H,
Kawashima T, Taki T, Kitamura T, Hayashi Y and Nosaka T:
Dimerization of MLL fusion proteins and FLT3 activation synergize
to induce multiple-lineage leukemogenesis. J Clin Invest.
115:919–929. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
44
|
Nosaka T, Morita S, Kitamura H, Nakajima
H, Shibata F, Morikawa Y, Kataoka Y, Ebihara Y, Kawashima T, Itoh
T, et al: Mammalian twisted gastrulation is essential for
skeleto-lymphogenesis. Mol Cell Biol. 23:2969–2980. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nosaka T, Kawashima T, Misawa K, Ikuta K,
Mui AL and Kitamura T: STAT5 as a molecular regulator of
proliferation, differentiation and apoptosis in hematopoietic
cells. EMBO J. 18:4754–4765. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
ENCODE Project Consortium: An integrated
encyclopedia of DNA elements in the human genome. Nature.
489:57–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Smith KS, Rhee JW and Cleary ML:
Transformation of bone marrow B-cell progenitors by E2a-Hlf
requires coexpression of Bcl-2. Mol Cell Biol. 22:7678–7687. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Grifone R, Demignon J, Giordani J, Niro C,
Souil E, Bertin F, Laclef C, Xu PX and Maire P: Eya1 and Eya2
proteins are required for hypaxial somitic myogenesis in the mouse
embryo. Dev Biol. 302:602–616. 2007. View Article : Google Scholar
|
